Evidence map›Paper›PMID 37890995›Full record

ArticleTobacco control2025

Why did Swiss citizens vote to ban tobacco advertising?

Luc Lebon, Pascal Diethelm, Valentine Ballmer, Hugo Molineaux, Karin Zürcher, Jacques Cornuz

Abstract read
In one paragraph

Article in Tobacco control, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Electronic cigarette for smoking cessation: a fast-track Delphi consensus of French-speaking experts.Archives of public health = Archives belges de sante publique · 2025
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Luc LebonCenter for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland luc.lebon@unisante.ch.ORCID 0000-0002-6754-8033
Pascal DiethelmOxySuisse, Geneva, Switzerland.
Valentine BallmerCenter for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.
Hugo MolineauxOxySuisse, Geneva, Switzerland.
Karin ZürcherCenter for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.
Jacques CornuzCenter for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In February 2022, Swiss citizens agreed to modify the Swiss Constitution to ban tobacco advertising reaching children and adolescents. This case study analyses the arguments used by both opponents and supporters of the constitutional amendment. Opponents argued that the proposed regulation went too far, threatened the economy, restricted personal freedom, was superfluous as the current law already protected youth and that it opened the door to marketing bans of other harmful products. Proponents focused on youth protection and invoked the burden of smoking on public health and the fact that advertising bans are an effective evidence-based measure. A comparison with previous campaigns to ban tobacco advertising that had failed suggests factors accounting for the positive vote in 2022. These include the strategic framing of youth protection, the separation of tobacco from other issues (such as alcohol advertising), the deteriorating image of the tobacco industry and the ability of the proponents to mobilise a broad coalition of health and youth organisations, with improved funding and communication. The lessons may be instructive for other campaigns seeking to regulate commercial determinants of health.

Indexed as

AdvertisingTobacco IndustryTobacco ProductsAdolescentChildHumansPoliticsPublic HealthSmokingSwitzerlandAdvertising and PromotionDenormalizationPreventionPublic policyTobacco industry

Identifiers

PMID37890995
PMCPMC11877067

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.